Spanish Registry of Mohs Surgery

Completed

• Conditions: Neoplasms, Adnexal and Skin Appendage; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Melanoma; Dermatofibrosarcoma; Histiocytoma, Malignant Fibrous; Skin Neoplasms
• Interventions: Procedure: Mohs surgery

• Registration Number: NCT02310503
• Lead Sponsor: Fundación Academia Española de Dermatología

Brief Summary

REGESMOHS (Registro Español de cirugía de Mohs) aims at describing effectiveness of Mohs surgery, and patient, tumor and technique factors related to adverse events and tumor recurrence.

REGESMOHS is a prospective cohort, including all patients considered for Mohs surgery in participating centers. All consecutive patients are included. The only exclusion criteria are being under 18-years-old or legally incompetent. Pre-planned follow-up is as required by common clinical practice, but at least once a year for the study period.

Detailed Description

Not available

Study Timeline

• Study Start: 2013-07-01
• Study First Submitted: 2014-12-01
• Study First Submitted QC: 2014-12-04
• Study First Posted: 2014-12-08
• Primary Completion: 2020-02-29
• Study Completion: 2020-02-29
• Status Verified: 2020-05
• Last Update Submitted: 2020-05-04
• Last Update Posted: 2020-05-05

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 6000

Inclusion Criteria

• All consecutive patients considered for Mohs surgery

Exclusion Criteria

• Under 18 years-old
• Legally incompetent

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Mohs surgery	Mohs surgery	Patients treated using Mohs surgery. Other exposures considered include patient characteristics, preoperative care and technical variants.

Primary Outcome Measures

Name	Time	Method
Tumor recurrence	6 years

Secondary Outcome Measures

Name	Time	Method
Short term outcomes	1 month	Bleeding, infection, abnormal scar, necrosis
Use of resources	During surgery	Need for admission, type of anesthesia, number of surgical steps, participating doctors,time in surgery room.
Impairments of body function and structure	6 years	presence of: abnormal scar, ectropion, nostril alteration, oral sphincter incompetence,other

Trial Locations

Locations (15)

Hospital Santa Creu i Sant Pau; 🇪🇸 Barcelona, Spain

Hospital Universitario de Cruces; 🇪🇸 Barakaldo, Spain

Hospital Quirón Teknon; 🇪🇸 Barcelona, Spain

Hospital Gregorio Marañon; 🇪🇸 Madrid, Spain

Complejo Asistencial Universitario de León; 🇪🇸 León, Spain

Hospital de la Princesa; 🇪🇸 Madrid, Spain

Hospital Universitario Fundación de Alcorcón; 🇪🇸 Madrid, Spain

Clínica Quirón; 🇪🇸 Madrid, Spain

Hospital del Mar; 🇪🇸 Barcelona, Spain

Instituto Valenciano de Oncología; 🇪🇸 Valencia, Spain

Complejo Hospitalario Universitario de Guadalajara; 🇪🇸 Guadalajara, Spain

Clínica Universitaria de Navarra; 🇪🇸 Pamplona, Spain

Hospital La Zarzuela; 🇪🇸 Madrid, Spain

Hospital Manises; 🇪🇸 Valencia, Spain

Complexo Hospitalario Universitario de Santiago; 🇪🇸 Santiago de Compostela, Spain